Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy
-
Published:2022-07-05
Issue:9
Volume:45
Page:1391-1398
-
ISSN:0174-1551
-
Container-title:CardioVascular and Interventional Radiology
-
language:en
-
Short-container-title:Cardiovasc Intervent Radiol
Author:
Korenblik R.ORCID, Olij B., Aldrighetti L. A., Hilal M. Abu, Ahle M., Arslan B., van Baardewijk L. J., Baclija I., Bent C., Bertrand C. L., Björnsson B., de Boer M. T., de Boer S. W., Bokkers R. P. H., Rinkes I. H. M. Borel, Breitenstein S., Bruijnen R. C. G., Bruners P., Büchler M. W., Camacho J. C., Cappelli A., Carling U., Chan B. K. Y., Chang D. H., choi J., Font J. Codina, Crawford M., Croagh D., Cugat E., Davis R., De Boo D. W., De Cobelli F., De Wispelaere J. F., van Delden O. M., Delle M., Detry O., Díaz-Nieto R., Dili A., Erdmann J. I., Fisher O., Fondevila C., Fretland Å., Borobia F. Garcia, Gelabert A., Gérard L., Giuliante F., Gobardhan P. D., Gómez F., Grünberger T., Grünhagen D. J., Guitart J., Hagendoorn J., Heil J., Heise D., Herrero E., Hess G. F., Hoffmann M. H., Iezzi R., Imani F., Nguyen J., Jovine E., Kalff J. C., Kazemier G., Kingham T. P., Kleeff J., Kollmar O., Leclercq W. K. G., Ben S. Lopez, Lucidi V., MacDonald A., Madoff D. C., Manekeller S., Martel G., Mehrabi A., Mehrzad H., Meijerink M. R., Menon K., Metrakos P., Meyer C., Moelker A., Modi S., Montanari N., Navines J., Neumann U. P., Peddu P., Primrose J. N., Qu X., Raptis D., Ratti F., Ridouani F., Rogan C., Ronellenfitsch U., Ryan S., Sallemi C., Moragues J. Sampere, Sandström P., Sarriá L., Schnitzbauer A., Serenari M., Serrablo A., Smits M. L. J., Sparrelid E., Spüntrup E., Stavrou G. A., Sutcliffe R. P., Tancredi I., Tasse J. C., Udupa V., Valenti D., Fundora Y., Vogl T. J., Wang X., White S. A., Wohlgemuth W. A., Yu D., Zijlstra I. A. J., Binkert C. A., Bemelmans M. H. A., van der Leij C., Schadde E., van Dam R. M.
Abstract
Abstract
Study Purpose
The DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients with borderline resectable colorectal cancer liver metastases.
Methods
The DRAGON 1 trial is a worldwide multicenter prospective single arm trial. The primary endpoint is a composite of the safety of PVE/HVE, 90-day mortality, and one year accrual monitoring of each participating center. Secondary endpoints include: feasibility of resection, the used PVE and HVE techniques, FLR-hypertrophy, liver function (subset of centers), overall survival, and disease-free survival. All complications after the PVE/HVE procedure are documented. Liver volumes will be measured at week 1 and if applicable at week 3 and 6 after PVE/HVE and follow-up visits will be held at 1, 3, 6, and 12 months after the resection.
Results
Not applicable.
Conclusion
DRAGON 1 is a prospective trial to assess the safety and feasibility of PVE/HVE. Participating study centers will be trained, and procedures standardized using Work Instructions (WI) to prepare for the DRAGON 2 randomized controlled trial. Outcomes should reveal the accrual potential of centers, safety profile of combined PVE/HVE and the effect of FLR-hypertrophy induction by PVE/HVE in patients with CRLM and a small FLR.
Trial Registration
Clinicaltrials.gov: NCT04272931 (February 17, 2020). Toestingonline.nl: NL71535.068.19 (September 20, 2019).
Funder
KWF Kankerbestrijding Maastricht Universitair Medisch Centrum Abbott Vascular Guerbet National Institute for Health Research
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging
Reference25 articles.
1. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006;24:3939–45. 2. Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250:540–8. 3. van Gulik TM, van den Esschert JW, de Graaf W, et al. Controversies in the use of portal vein embolization. Dig Surg. 2008;25:436–44. 4. van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36:25–34. 5. Shindoh J, Tzeng CW, Aloia TA, et al. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg. 2014;18:45–51.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|